These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 11995446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C, Oshima CT, Lanzoni VP, Forones NM.
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [Abstract] [Full Text] [Related]

  • 5. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
    Fujii T, Zen Y, Harada K, Niwa H, Masuda S, Kaizaki Y, Watanabe K, Kawashima A, Nakanuma Y.
    Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
    [Abstract] [Full Text] [Related]

  • 6. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma.
    Shimada A, Shiota G, Miyata H, Kamahora T, Kawasaki H, Shiraki K, Hino S, Terada T.
    Cancer Res; 1998 Oct 01; 58(19):4434-8. PubMed ID: 9766675
    [Abstract] [Full Text] [Related]

  • 7. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
    Idobe Y, Murawaki Y, Kitamura Y, Kawasaki H.
    Hepatogastroenterology; 2003 Oct 01; 50(49):54-9. PubMed ID: 12629989
    [Abstract] [Full Text] [Related]

  • 8. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K, Fujikawa K, Sugimoto K, Ito T, Yamanaka T, Suzuki M, Yoneda K, Sugimoto K, Takase K, Nakano T.
    Int J Mol Med; 2006 Jul 01; 18(1):77-81. PubMed ID: 16786158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
    Azzaroli F, Colecchia A, Lodato F, Trerè D, Bacchi Reggiani ML, Festi D, Prati GM, Accogli E, Casanova S, Derenzini M, Roda E, Mazzella G.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):129-36. PubMed ID: 16803611
    [Abstract] [Full Text] [Related]

  • 11. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
    Nonomura T, Masaki T, Morishita A, Jian G, Uchida N, Himoto T, Izuishi K, Iwama H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.
    Int J Oncol; 2007 Jan 01; 30(1):105-11. PubMed ID: 17143518
    [Abstract] [Full Text] [Related]

  • 12. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM, Sakaida I, Okita K.
    Gastroenterology; 2006 Jun 01; 130(7):2087-98. PubMed ID: 16762631
    [Abstract] [Full Text] [Related]

  • 13. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
    Kalogeraki A, Garbagnati F, Santinami M, Zoras O.
    Cancer; 2002 Oct 25; 96(5):301-5. PubMed ID: 12378598
    [Abstract] [Full Text] [Related]

  • 14. Malignant transformation of the cultured human hepatocytes induced by hepatitis C virus core protein.
    Shan Y, Chen XG, Huang B, Hu AB, Xiao D, Guo ZM.
    Liver Int; 2005 Feb 25; 25(1):141-7. PubMed ID: 15698411
    [Abstract] [Full Text] [Related]

  • 15. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
    Uenishi T, Kubo S, Hirohashi K, Yamamoto T, Ogawa M, Tanaka H, Shuto T, Kinoshita H.
    Hepatogastroenterology; 2003 Feb 25; 50(52):1101-4. PubMed ID: 12845990
    [Abstract] [Full Text] [Related]

  • 16. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ.
    Hepatology; 2002 Jun 25; 35(6):1431-40. PubMed ID: 12029628
    [Abstract] [Full Text] [Related]

  • 17. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
    Wada A, Fukui K, Sawai Y, Imanaka K, Kiso S, Tamura S, Shimomura I, Hayashi N.
    J Hepatol; 2006 Jan 25; 44(1):142-50. PubMed ID: 16298452
    [Abstract] [Full Text] [Related]

  • 18. [Effects of nitric oxide on mitochondrial permeability transition and cytochrome C of human hepatocellular carcinoma cell lines].
    Jiang XM, Zheng DL, Lin JY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct 25; 26(5):519-23. PubMed ID: 15562764
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.
    Gastroenterology; 2007 Nov 25; 133(5):1649-59. PubMed ID: 17983809
    [Abstract] [Full Text] [Related]

  • 20. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M, Mikuni M, Matsumura H, Nakamura H, Oshiro S, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Tanaka N, Arakawa Y.
    Liver Int; 2005 Apr 25; 25(2):226-35. PubMed ID: 15780043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.